Dystocia in the bitch: A retrospective study of 182 cases

In a retrospective study of 182 cases of canine dystocia, no relationship was found between either breed or age and occurrence of dystocia. However, medium-sized breeds (between 12.7 and 20.5 kg bodyweight) were slightly over represented. Of the bitches that had whelped previously, 42 per cent had experienced dystocia. The dystocia was of maternal origin in 75.3 per cent of the cases, mainly due to uterine inertia, while 24.7 per cent were of fetal origin, mainly resulting from malpresentations/malorientations. The most common reason for dystocia was primary, complete uterine inertia (48.9 per cent) and 40 per cent of the bitches with this problem had small litters of one or two pups. The most common treatment was calcium and, or, oxytocin injection followed by a caesarean section. Digital manipulation including forceps delivery and, or, medical treatment was successful in only 27.6 per cent of the cases. Of the bitches studied, 65.7 per cent had a caesarean section. Pup deaths occurred in 52.2 per cent of the litters. Among bitches that had been treated within one to four-and-a-half hours after the beginning of second stage labour, 5.8 per cent of the pups died, whereas the corresponding value for bitches that had been treated between five and 24 hours after the beginning of second stage labour was 13.7 per cent. The total frequency of pup deaths was 22.3 per cent. These findings show that early diagnosis and prompt treatment are crucial in reducing the pup death rate in cases of dystocia.     

Safety and efficacy of mid-term pregnancy termination using aglepristone in dogs

O bjectives : To investigate effects and side effects of aglepristone in terminating pregnancy in bitches.
M ethods : Twenty-two bitches were treated in mid-pregnancy with subcutaneous injections of aglepristone at a total dose of 20 mg/kg. Short-term follow-up (one to two weeks after treatment) included clinical examination and abdominal ultrasonography in 18 of the dogs. Long-term telephone follow-up was recorded for all 22 dogs.
R esults : Pregnancy was terminated in 21 bitches (95 per cent). Signs of abortion occurred one to eight days after treatment. Vaginal discharge was evident in 17 (77 per cent) dogs. Obvious signs of parturition were seen in nine (41 per cent) dogs. Eight dogs (36 per cent) developed anorexia, and in two (9 per cent) of the dogs a local reaction at the injection site was evident. Two dogs developed pyometra two and four years after treatment, respectively.
C linical S ignificance : Aglepristone, when administered in mid-gestation, is effective in terminating pregnancy. Side effects are few and transient.     

Equine Chorionic Gonadotropin and Human Chorionic Gonadotropin Stimulation Increase the Number of Luteinized Follicles and the Progesterone Level Compared with Cabergoline Stimulation in Anoestrus Bitches

In this study, ovarian morphologies and blood progesterone concentrations following oestrous induction in bitches were examined. Fifty‐three clinically healthy anoestrus bitches received cabergoline at a daily dose of 5 μg/kg of body weight per os for 21 days (group I) or subcutaneous equine chorionic gonadotropin at a dose of 20 IU/kg of body weight for five consecutive days with an additional 500 IU s.c. per bitch of human chorionic gonadotropin on the last day of treatment (group II). Twenty bitches that spontaneously displayed oestrous signs were left untreated and served as controls (group III). The induced oestrous rates and ovulation rates in groups I and II were 60.0% vs 64.3% and 86.7% vs 83.3%, respectively. Morphological assessments of the ovarian structures after ovariohysterectomy revealed an increase in the number of luteinized follicles and cysts in group II compared with the two other groups (p < 0.001). In contrast, the numbers of corpora lutea and follicles were similar in all groups. In accordance with the above‐mentioned alteration, the progesterone concentration in the gonadotropin group (II) was increased (p < 0.001) in the periovulatory period compared with the other two groups. During the entire sampling period, the progesterone profiles in the cabergoline (I) and control (III) groups were similar and typical of normally cycling bitches. In conclusion, gonadotropin treatment is associated with an increased progesterone level during the periovulatory period that probably originates from luteinized follicles, whereas cabergoline treatment induces cycles with both physiological progesterone concentrations and ovarian morphologies.     

Practical use of a combination of a dopamine agonist and a synthetic prostaglandin analogue to terminate unwanted pregnancy in dogs

The combination of a dopamine agonist, caber-goline, and a synthetic analogue of prostaglandin F_2a, cloprostenol, was used to induce termination of pregnancy from day 25 after the estimated luteinising hormone surge (day 27 ± 4 after the first mating) in five mature beagle bitches. Caber-goline was administered orally at 5 μg/kg daily and cloprostenol was injected subcutaneously at 1 μg/kg every other day. Treatment efficacy, in terms of pregnancy termination, was 100 per cent. Termination always took place by resorption of the fetuses. No side effects were observed. A mean of three injections of cloprostenol and nine days of cabergoline treatment was necessary to eliminate all signs of gestation. Termination was in each case accompanied by a decline in plasma progesterone (to less than 1 ng/ml) within 72 hours of initiation of treatment. In a control group of five, untreated bitches, plasma progesterone remained elevated throughout a corre-     

Treatment of pseudopregnancy in the bitch with cabergoline, an ergoline derivative

Cabergoline, a new prolactin inhibitor, was evaluated clinically in 143 bitches with pseudopregnancy and, or, false lactation, 14 cases of lactation after ovariohysterectomy for the removal of dead fetuses, 12 cases of persisting lactation after early weaning, and five cases of eclampsia. The drug was administered as a once-daily oral treatment (on food) in 139 cases or as subcutaneous injections at 48 hour intervals (maximum four injections) at a dose of 5, 2–5 or 1–5 μg/kg bodyweight in 35 cases. Improvement was evident within three to four days, and in 80 per cent of the cases clinical signs (abnormal behaviour, mammary gland swelling. milk secretion) had been significantly reduced or had disappeared within seven days. Treatment was successful in 95 per cent of the cases. Emesis was the only objectionable clinical side effect, being seen in 3 per cent of orally treated animals and necessitated withdrawal of one dog from the study. Vomiting occurred after the first (65-7 per cent) and second (22-9 per cent) injection only.     

Comparison of the use of cabergoline and gonadotrophin to treat primary and secondary anoestrus in bitches

Objective To determine the efficacy and reliability of cabergoline and pregnant mare's serum gonadotrophin (PMSG) for induction of oestrus in bitches with primary or secondary anoestrus. Procedures We studied 39 healthy bitches of various breeds aged 2–6 years and in primary or secondary anoestrus: 20 bitches were administered 5 µg/kg/day cabergoline orally until day 2 after the onset of pro‐oestrus or for a maximum of 42 days, and 19 bitches were administered 20 IU/kg/day PMSG intramuscularly for 5 consecutive days, followed by an additional single injection of 25 IU/kg of human chorionic gonadotrophin on the fifth day. Results The rates of oestrus induction in the primary and secondary anoestrous bitches treated with cabergoline and PMSG were found to be similar. Pregnancy and whelping rates in the cabergoline group were statistically different from the rates in the PMSG group (P < 0.001). Conclusion Cabergoline is more effective and reliable for the induction of a fertile oestrus in bitches with primary or secondary anoestrous.     

Effect and mechanisms of the anti-prolactin drug cabergoline on pseudopregnancy in the bitch

A potent anti-prolactin drug, cabergoline, administered orally for five days, was clinically successful in treating three different clinical manifestations of pseudopregnancy in referred bitches. The clinical conditions treated were categorised as standard pseudopregnant bitches (n=8), those previously unsuccessfully treated with hormones (n=10) and those which had behavioural pseudo pregnancy following ovariohysterectomy (n=8). The number of bitches whose owners reported a 'good'response was seven out of eight, six out of 10 and six out of eight, respectively. There were very few side effects in that only one bitch vomited following treatment. The clinical response did not necessarily appear to be related to an alteration in circulating prolactin concentrations, suggesting that the drug may have a direct effect on the tissues as well as in most cases reducing the plasma prolactin concentrations.     

Comparisons of different combinations of analogues of PGF2 alpha and dopamine agonists for the termination of pregnancy in dogs.

Groups of five pregnant bitches were treated to terminate the pregnancy with four combinations of drugs, starting 28 days after the estimated surge of luteinising hormone (LH), 22 to 28 days after the first mating. The treatments were: cabergoline administered orally for 10 days at a dose of 5 micrograms/kg and a single subcutaneous injection of 2.5 micrograms/kg cloprostenol at the start of the treatment; the same dose of cabergoline plus two doses of 1 microgram/kg cloprostenol administered on days 28 and 32 after the LH surge; bromocryptine administered orally at a dose of 30 micrograms/kg three times a day for 10 days plus a single dose of 2.5 micrograms/kg cloprostenol; the same dose of bromocryptine plus two doses of 1 microgram/kg cloprostenol; and a group of five pregnant bitches was left untreated. The pregnancies were terminated in all but one of the treated bitches, in each case by resorption of the fetuses. There were few side effects in the bitches treated with two doses of 1 microgram/kg cloprostenol, and were present but acceptable in those treated with one dose of 2.5 micrograms/kg. Plasma progesterone concentrations decreased to less than 1 ng/ml within 72 hours of the start of treatment and remained low except in the bitch in which pregnancy was not terminated. In the five untreated bitches, plasma progesterone remained high and they whelped normally. In the treated groups, the intervals between successive displays of oestrus were reduced by approximately 70 days in comparison with previous cycles or with the control group, but the fertility of the dogs was not affected adversely.     

Protection of puppies against canine herpesvirus by vaccination of the dams.

Six bitches free of canine herpesvirus 1 (CHV-1) were vaccinated against the virus; a first injection was given 10 days after the presumed date of mating and a second six weeks later. Six similar bitches were left unvaccinated as controls, and all the pups were challenged oronasally with a virulent strain of CHV-1 at three days of age. All the vaccinated bitches seroconverted and had high antibody titres when the puppies were challenged, but the control bitches remained seronegative. In the control group, 62 per cent (18 of 29) of the pups died of CHV-1-induced disease; most of them showed typical clinical signs and macroscopic lesions, and CHV-1 infection was confirmed by the isolation of the virus or by PCR. None of the puppies in the vaccinated group died of CHV-1 infection. The efficacy of the vaccine was confirmed in CHV-1-positive breeding units. The rate of pregnancy tended to be higher in vaccinated bitches and the mortality of pups before weaning was significantly reduced in the litters born to vaccinated bitches.     

Evaluation of Cabergoline and Buserelin Efficacy for Oestrous Induction in the Bitch

The purpose of this work was to compare two different protocols of oestrous induction, using either a dopamine agonist (cabergoline) or a GnRH agonist (buserelin) in anoestrus bitches. The clinical trial involved 22 Beagle bitches, randomly allotted to two treatment groups: group A (n = 12) was orally administered cabergoline (Galastop^®; Centralvet‐Vetem, Milan, Italy; 5 μg/kg SID), until the onset of cytological oestrus or for a maximum of 30 days and group B (n = 10) was treated with buserelin acetate, (Suprefact^®; Aventis Pharma, Milan, Italy), administered subcutaneously t.i.d., at 1.5 μg/kg for 11 days and 0.75 μg/kg for the following 3 days. Blood samples were collected twice a week to measure progesterone and prolactin concentration. Both cabergoline and buserelin produced a significant early decline in prolactin concentration (p < 0.01), but the effect of cabergoline lasted longer. Progesterone concentration was significantly affected by buserelin administration, showing a significant increase (p < 0.01) from day 3 to day 6 of treatment. Cabergoline confirmed its effectiveness in inducing oestrus as 10 of 12 bitches responded to the treatment, were mated and whelped. On the contrary, oestrus was observed in only three of 10 buserelin‐treated bitches and in two of them 7 and 13 days after the end of treatment. These same two bitches accepted mating and conceived. The results suggest that in a clinical setting, dopaminergic treatment is the treatment of choice as it yields more consistent results and involves a much easier administration protocol.     

Timing the mating of dogs on the basis of blood progesterone concentration

The optimal time for mating bitches was determined by measuring the progesterone concentration in peripheral blood three times a week after the start of vulval bleeding. Of 104 bitches with reduced fertility 81 (78 per cent) became pregnant and of 112 bitches with normal fertility 105 (94 per cent) became pregnant. Of 121 bitches mated once, 102 (84 per cent) became pregnant, and of 95 bitches mated more than once, 84 (88 per cent) became pregnant. The mean (+/- sd) interval between the start of vulval bleeding and the optimal time for mating in 88 bitches was 11.8 +/- 3.1 days. The blood progesterone concentration appears to be an excellent indicator of the best time for mating, particularly in bitches with reduced fertility.     

Evaluation of a new non-hormonal substance for terminating pregnancy in bitches in clinical trials

A new non-hormonal contragestational agent (DL 717-IT), the 2-(4 chlorophenyl)-s-triazole |5,1-a|-isoquinoline, was tested in clinical trials to determine its efficacy for interrupting the pregnancy in the bitch. Five hundred and sixty-five bitches were given a single intramuscular injection of the drug between the first and 15th day after the mating. Of the 475 bitches that received 2–5 mg/kg, 430 (90-5 per cent) did not whelp at all, 15 (3-2 per cent) delivered a few stillborn or weak puppies that died some hours after birth, and 30 (6-3 per cent) delivered at least one normal live pup. Of 90 bitches treated with 3–5 mg/kg, 87 (96-7 per cent) did not whelp at all, two (2-2 per cent) delivered a few stillborn or weak puppies that died some hours after birth, and one (1 1 per cent) delivered normal live puppies. DL 717-IT, owing to the high effectiveness and minimal side effects, must be considered a very reliable drug for the interruption of pregnancies in the bitch.     

Prevalence of fetal resorption in stray dogs in Yucatan, Mexico

OBJECTIVES: To determine the prevalence of fetal resorption in 77 pregnant bitches and its association with the age, size and body condition score of the bitch and to determine the frequency of transuterine migration of embryos. METHODS: The number and position of embryos or fetuses and placental zones were registered postmortem. The prevalence of fetal losses was determined by comparing the number of corpora lutea with the number of embryos or fetuses in each bitch. The prevalence of transuterine migration of embryos was determined by correlating the number of fetuses in each horn and the number of corpora lutea in the ipsilateral ovary. RESULTS: Fetal resorption zones were demonstrated in 42.9 per cent of the bitches. However, pregnancy continued in 84.9 per cent of cases. Of the fetal losses, 25.9 per cent were determined by counting the number of corpora lutea and viable embryos or fetuses. Young bitches tended to have a higher probability of fetal resorption than adult bitches (P<0.06). The presence of fetal resorption zones was not associated with size or body condition. Transuterine migration of embryos had occurred in 15.8 per cent of the bitches. CLINICAL SIGNIFICANCE: This study demonstrated that embryo resorption is a normal event in the bitches, with a higher prevalence than previously thought.     

A Review of Canine Pseudocyesis

The purpose of this article is to review the most relevant features of the physiology, clinical signs, diagnosis, treatment and prevention of canine pseudocyesis (PSC). This is a physiological syndrome, characterized by clinical signs such as: nesting, weight gain, mammary enlargement, lactation and maternal behaviour, which appears in non‐pregnant bitches at the end of metaoestrus. PSC is a frequent finding in domestic dogs. Although it is generally admitted that prolactin (PRL) plays a central role in the appearance of PSC, its precise aetiophysiology is not completely understood yet. A number of clinical studies suggest that at some point of metaoestrus circulating PRL levels rise in overtly pseudopregnant bitches. Individual differences in sensitivity to PRL as well as the existence of molecular variants of canine PRL with different bioactivity versus immunoreactivity ratios may help clarify the aetiopathology of PSC. Diagnosis of PSC is based on the presence of typical clinical signs in metaoestrous non‐pregnant bitches. Considering that PSC is a self limiting physiological state, mild cases usually need no treatment. Discouraging maternal behaviour and sometimes fitting Elizabethan collars to prevent licking of the mammary glands may suffice in these cases. Sex steroids (oestrogens, progestins and androgens) have been traditionally used to treat PSC but the side‐effects usually outweigh the benefits of these medications. Inhibition of PRL release by ergot derivatives [ bromocriptine (10–100 μg/kg per day for 10–14 days], cabergoline (5 μg/kg per day during 5–10 days), metergoline (0.2 mg/kg per day during 8–10 days) has proved to be effective for the treatment of canine PSC. Although some of these ergot derivatives present some untoward side‐effects, they are transient and can usually be managed. Predisposed bitches not intended for breeding should be spayed as ovariectomy is the only permanent preventive measure.     

Treatment of spontaneous pyometra in 22 bitches with a combination of cabergoline and cloprostenol

Twenty-two bitches with ultrasonographically diagnosed spontaneous pyometra were treated with a combination of 5 microg/kg cabergoline per day and 5 mug/kg cloprostenol every third day, and potentiated sulphonamide twice a day. Bitches with either open-cervix or closed-cervix pyometra showed a rapid clinical improvement, associated with a reduction in plasma progesterone concentration, increased vulval discharge and a reduction in the diameter of the uterus. The haematological profiles of 21 of the bitches returned to normal within six days of treatment, and their biochemical profiles returned to normal within nine days; 19 of the bitches were managed successfully by a 10-day period of treatment. Two bitches required a further three days of treatment, and in one bitch with a partial uterine torsion the treatment was not successful. Adverse effects of the treatment were limited to the 60 minutes immediately after the administration of prostaglandin, and included retching, vomiting, mild abdominal straining, diarrhoea and panting. The incidence of adverse effects was reduced after each successive dose of prostaglandin. Eleven of the 21 successfully treated bitches were mated at the next oestrus, and seven became pregnant; their litters were smaller than the published breed averages. In four of the bitches the pyometra recurred after the next oestrus.     

Oestrus control in bitches with chlormadinone acetate

A clinical study of oestrus control in bitches with chlormadinone acetate (CMA) is reported. The commercial 1-0 per cent crystalline suspension of CMA was injected subcutaneously at a dose of 3 mg/kg, or somewhat lower for the largest animals. Treatment was initiated always in anoestrus and was repeated twice annually for as long as requested. The longest, 9-year, period of anoestrus was achieved by twenty repeated treatments. A total of 2,471 treatments were given to 568 bitches (an average of 4-4 treatments per bitch) during a period of over 10 years, with an efficacy of 98 per cent. The incidence of false pregnancy, uterine inflammatory disorders and mammary nodules in the treated group were compared to those of an age-related control group of 487 bitches that did not receive hormonal treatment. A lower incidence of false pregnancy and the two clinical entities was observed in the group of treated animals. It is concluded that CMA can be used safely and reliably for oestrus control in bitches and is therefore, an appropriate alternative for ovariohysterectomy.     

Treatment of urinary incontinence in bitches by endoscopic injection of glutaraldehyde cross-linked collagen

Thirty-two spayed bitches with urinary incontinence due to urethral sphincter incompetence, non-responsive to phenylpropanolamine administration, were treated by urethral submucosal injection of glutaraldehyde cross-linked collagen. Urinary incontinence resolved after a single injection in 19 of the bitches. Additional medication with phenylpropanolamine was necessary in five of these dogs, however. Of the 13 bitches that remained incontinent, the injections were repeated in nine. This resulted in a return to continence in five dogs, although two of these required additional medication for complete continence. The cure rate due to collagen injections alone is 53 per cent (17 of the 32 cases). A total of 41 injections were performed and no postoperative complications were observed.     

Vaginal cytology and cervicovaginal mucus arborisation in the breeding management of bitches

Fifty bitches were mated on the basis of results of vaginal cytological and cervicovaginal mucus arborisation examination. When these were compared with a control group of 50 bitches mated on days 10 and 12 after the onset of proestrus there was a significant increase in pregnancy rate from 78 to 92 per cent. The litter size and bitch productivity was also increased, although this was not statistically significant. Forty-two per cent of bitches had two peaks of anuclear epithelial cells in the vaginal smear, separated by a mean of 3–6 ± 1–5 (SD) days. For these bitches, the maximum percentage of anuclear cells at the second peak was between 57 and 98 per cent, and the mean interval between the calculated day of the surge in plasma luteinising hormone (LH) and the second peak of anuclear cells was 4-4 ± 2-0 days. In bitches with one peak of anuclear epithelial cells, the maximum percentage of anuclear cells was between 43 and 94 per cent and the mean interval between the calculated day of the LH surge and the peak of anuclear cells was 1–9 ± 2-1 days. Arborisation of mucus collected from the anterior vagina was noted in all bitches; the mean interval between the calculated day of the LH surge and the peak of ferning was 2–3 ± 2-1 days. The collection of exfoliative cells by aspiration from the cranial vagina and the assessment of the anuclear cell index, may allow the identification of the fertile period after the surge of plasma LH. The anuclear cell index offers advantages over other methods of classification of exfoliative vaginal cells. When used in combination with examination of arborisation of cervicovaginal mucus this method can improve the breeding management of bitches.     

A preliminary study of pregnancy termination in the bitch with slow-release formulations of prostaglandin analogues

Forty-two beagle bitches at gestational ages from 4 to 35 days were treated with various formulations of the prostaglandin analogues fluprostenol and cloprostenol at doses from 10–40 μg/kg in an attempt to terminate pregnancy. Pregnancy was confirmed and the effect of treatment assessed by euthanasia and post-mortem examination to detect viable foetuses or resorbing implants twenty-one days after prostaglandin administration. Five of the bitches treated with an aqueous solution of cloprostenol by subcutaneous injection showed unacceptable side effects but both compounds in a slow release injectable formulation or impregnated into intravaginal devices had a luteolytic effect with only mild side effects in occasional bitches. Successful response to treatment in terms of sustained depression of plasma progesterone concentrations and pregnancy termination was 80 per cent at gestation stages of 25 days or over but only 27 per cent when given earlier in pregnancy. Mature follicles developed in two bitches which aborted following treatment at 14 days and returned to oestrus 10–14 days later. These preliminary findings show that slow-release formulations of fluprostenol and cloprostenol can cause complete luteolysis in the bitch.     

Ultrasound evaluation of pregnancy and spontaneous embryonic resorption in the bitch

One hundred and one pregnant bitches were imaged using real-time B-mode ultrasonography. The accuracy of predicting fetal number was 38 per cent during early pregnancy and was lower with later examinations. If bitches were examined in early pregnancy and estimated to have five pups or more, or four pups or less, the predictive value of ultrasound was 100 per cent and 83-3 per cent, respectively. The ultrasonographic appearance of one case of abortion and five cases of isolated spontaneous embryonic resorption were characterised. The resorptions did not apparently interfere with adjacent remaining conceptuses. The components of embryonic resorption were found to be; reduced volume and changes in echogenicity of embryonic fluid, loss of embryonic mass and heartbeat, collapse of the conceptus with thickening and inward bulging of the uterine wall and reduced size in comparison with adjacent conceptuses. Following resorption the uterus was moderately hypoechoic in appearance, similar to after parturition. No risk factors were correlated with resorption or abortion.